معرفی
Fredrik Elinder is a Professor and Deputy Head of Department at the Department of Biomedical and Clinical Sciences (BKV) at Linköping University, Sweden. He leads research in molecular physiology of voltage-gated ion channels with a focus on neurological and cardiovascular applications. His work bridges basic science and translational research, particularly in developing drugs targeting epilepsy and cardiac arrhythmias.
Elinder's research group investigates how substances modulate ion channel function at the molecular level, with key contributions to understanding potassium channel pharmacology and lipid-channel interactions. His team collaborates closely with SciLifeLab Linköping, leveraging advanced technologies in biophysics and drug discovery. Notable achievements include discovering novel antiseizure compounds derived from conifer resin acids and identifying molecular mechanisms underlying nerve impulse regulation.
He has received prestigious recognition including the Onkel Adam Award (2021) for outstanding research contributions. Elinder's work has implications for treating epilepsy, chronic pain, and cardiac disorders, with multiple patents and industry collaborations advancing drug development pipelines.
